Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories
Ravi Das, Grace Gale, Katie Walsh, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Interventions for suicide and self-injury: A meta-analysis of randomized controlled trials across nearly 50 years of research.
Kathryn R. Fox, Xieyining Huang, Eleonora M. Guzmán, et al.
Psychological Bulletin (2020) Vol. 146, Iss. 12, pp. 1117-1145
Closed Access | Times Cited: 237
Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 100
Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
John H. Krystal, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 41-50
Open Access | Times Cited: 89
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 856-856
Open Access | Times Cited: 86
Alcohol use disorders and ADHD
Mathias Luderer, Josep Antoni Ramos‐Quiroga, Stephen V. Faraone, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 648-660
Closed Access | Times Cited: 63
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
Sanket B. Raut, Padmaja A Marathe, Liza van Eijk, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108195-108195
Open Access | Times Cited: 43
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 38
Long term structural and functional neural changes following a single infusion of Ketamine in PTSD
Or Duek, Nachshon Korem, Yutong Li, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1648-1658
Open Access | Times Cited: 23
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9
Memory persistence: from fundamental mechanisms to translational opportunities
Santiago A. Merlo, Mariano Belluscio, María E. Pedreira, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Jérémie Richard, Albert Garcia‐Romeu
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
A Review of Nonanesthetic Uses of Ketamine
Abby Pribish, Nicole Wood, Arun Kalava
Anesthesiology Research and Practice (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 61
The emergence of ketamine as a novel treatment for posttraumatic stress disorder
Adriana Feder, Sarah Rutter, Daniela Schiller, et al.
Advances in pharmacology (2020), pp. 261-286
Closed Access | Times Cited: 56
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 35
Ketamine Treatment for Alcohol Use Disorder: A Systematic Review
Michael Kelson, Justin M Burnett, Amy Matthews, et al.
Cureus (2023)
Open Access | Times Cited: 19
Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells
Ming Li, Xueke Yang, Jian Yang, et al.
Neuron (2024) Vol. 112, Iss. 18, pp. 3192-3210.e6
Closed Access | Times Cited: 6
Reconsolidation-based treatment for fear of public speaking: a systematic pilot study using propranolol
James W. B. Elsey, Anna I. Filmer, Harriet R. Galvin, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 39
Therapeutic potential of ketamine for alcohol use disorder
Stephen Worrell, Thomas J. Gould
Neuroscience & Biobehavioral Reviews (2021) Vol. 126, pp. 573-589
Closed Access | Times Cited: 35
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019
John Corkery, Wan-Chu Hung, Hugh Claridge, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 11, pp. 1324-1348
Open Access | Times Cited: 33
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.
Nicolas Garel, Christina McAnulty, Kyle T. Greenway, et al.
Drug and Alcohol Dependence (2022) Vol. 239, pp. 109606-109606
Open Access | Times Cited: 25
The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review
Charlotte Goldfine, Jeremiah J. Tom, Dana D. Im, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 14
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
Kirsten C. Morley, Christina J. Perry, Joshua Watt, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1291-1303
Closed Access | Times Cited: 32
Amygdala Allostasis and Early Life Adversity: Considering Excitotoxicity and Inescapability in the Sequelae of Stress
Jamie L. Hanson, Brendon M. Nacewicz
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top